COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #8 of 231
3/31 Late treatment study
Chen et al., medRxiv doi:10.1101/2020.03.22.20040758 (Preprint)
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Source   PDF   Share   Tweet
62 patients. RCT showing significantly faster recovery with HCQ. 13% progressed to severe cases in the control group, versus 0% for the treatment group. Significant improvement seen in pneumonia on chest CT for 61% of treated patients and 16% of control patients.

Chen et al., 3/31/2020, Randomized Controlled Trial, China, Asia, preprint, 9 authors.
risk of no improvement in pneumonia at day 6, 57.0% lower, RR 0.43, p = 0.04, treatment 6 of 31 (19.4%), control 14 of 31 (45.2%).
Details of all 231 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit